Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label Lamazym trial in alpha-mannosidosis
2011-004355-40Phase 2Completed
- Sponsor
- Zymenex
- Start
- Jan 2012
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of velmanase alfa in alpha-mannosidosis, sponsored by Zymenex. Started Jan 2012; status: completed.
02
Drugs
velmanase alfa
03
Conditions
alpha-mannosidosis
Beyond the preview
Go deeper on 2011-004355-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004355-40.